Number of Shares
2,825.00
Current Holdings Value*
kr393,350.00
% of Portfolio
1.86%
Total Estimate Gain
kr1.72 Mil
% of Total Estimate Gain
27.06%

Federated Hermes Global Equity Fund's Novo Nordisk AS Holding Summary

As of 2024-08-31, Federated Hermes Adviser Series held 2,825.00 shares of Novo Nordisk AS(OCSE:NOVO B), totaling kr393,350.00. This investment constitutes 1.86% of their stock portfolio, and Federated Hermes Adviser Series now holds 0% of the outstanding Novo Nordisk AS(OCSE:NOVO B) stock.

The initial trade took place in 2019Q4. And since then Federated Hermes Global Equity Fund has made 8 purchases of OCSE:NOVO B, at an average price of kr467.90, for a total of 13,596.00 shares. In addition, there have been 6 sales at an average price of kr635.30 for 10,771.00 shares. Based on historical transaction data and OCSE:NOVO B's current price of kr438.95, Federated Hermes Global Equity Fund's estimated gain on his OCSE:NOVO B holdings is kr1.72 Mil, reflecting a 27.06% gain to date.

Federated Hermes Global Equity Fund OCSE:NOVO B (kr438.95) Holding Chart

Federated Hermes Global Equity Fund OCSE:NOVO B (kr438.95) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price kr-/Share
Shares Sold 0 Average Price kr-/Share
Current Price kr0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1